Published by
TDPel Media
TDPel Media
Airlangga University and Biotis Pharmaceutical Indonesia are leading research on the “Merah Putih” (“Red White”) vaccine, which is named after the colors of the Indonesian national flag. Since its inception in 2020, the project has been delayed, but if the trials are successful, authorities hope to be able to deploy it by the middle of 2022. Budi Gunadi Sadikin, Indonesia’s health minister, said the medicine, which would be rolled out in the last stages of the country’s immunization campaign, might be donated to other countries as a booster shot or a vaccine for children aged three to six. “I …